Fact based stock research
Medika d.d. (ZGSE:MDKA)

HRMDKARA0000

Medika d.d. stock research in summary

medika.hr


Medika d.d. shares have a market-typical stock price level. They are safely financed and show above average growth, but are poor value. We recommend evaluating whether the future of the company Medika d.d. is typical for this industry which the market average price level of the shares suggests. If you believe that the future of the company is above average, that could be an argument for buying the shares and vice versa.


Latest Obermatt Ranks


Value Rank 46
Growth Rank 72
Safety Rank 92
Combined Rank 82
Country Croatia
Industry Health Care Distributors
Index IDX Composite
Size class Medium

November 3, 2022. Stock data may be delayed. Login to get the most recent research.

Add to Watchlist
Filter Similar Stocks
Similar Top 10

Research History: Medika d.d.

RESEARCH HISTORY 2019 2020 2021 2022
VALUE
VALUE 100
100
98
46
GROWTH
GROWTH 69
69
64
72
SAFETY
SAFETY 50
47
78
92
COMBINED
COMBINED 94
91
98
82

Last update of Combined Rank: 3-Nov-2022. Financial reporting date used for calculating ranks: 3-Nov-2022. Stock research history is based on the Obermatt Method. The higher the rank, the better Medika d.d. is in the corresponding investment strategy.


Value Metrics in Detail

VALUE METRICS 2019 2020 2021 2022
PRICE VS. REVENUES (P/S)
PRICE VS. REVENUES (P/S) 98
98
85
81
PRICE VS. PROFITS (P/E)
PRICE VS. PROFITS (P/E) 100
93
83
85
PRICE VS. CAPITAL (Market-to-Book)
PRICE VS. CAPITAL (Market-to-Book) 92
90
62
43
DIVIDEND YIELD
DIVIDEND YIELD 84
96
94
1
CONSOLIDATED RANK: VALUE
CONSOLIDATED RANK: VALUE 100
100
98
46

Last update of Value Rank: 3-Nov-2022. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Medika d.d.; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2019 2020 2021 2022
REVENUE GROWTH
REVENUE GROWTH 82
71
19
34
PROFIT GROWTH
PROFIT GROWTH
43
STOCK RETURNS
STOCK RETURNS 34
80
92
88
CONSOLIDATED RANK: GROWTH
CONSOLIDATED RANK: GROWTH 69
69
64
72

Last update of Growth Rank: 3-Nov-2022. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Medika d.d..


Safety Metrics in Detail

SAFETY METRICS 2019 2020 2021 2022
LEVERAGE
LEVERAGE 12
10
56
83
REFINANCING
REFINANCING 98
100
70
70
LIQUIDITY
LIQUIDITY 46
51
76
84
CONSOLIDATED RANK: SAFETY
CONSOLIDATED RANK: SAFETY 50
47
78
92

Last update of Safety Rank: 3-Nov-2022. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Medika d.d. and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Medika d.d. from November 3, 2022.


We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.